MCA logo
MCA logo



Extracorporeal Life Support in Infarct-Related Cardiogenic Shock – Still Valid?

cardiogenic shock ECLS
Cardiogenic shock is the leading cause of death amongst patients hospitalized with acute myocardial infarction. Immediate revascularization of the culprit lesion is the only treatment available but mortality still remains high. The use of extracorporeal life support (ECLS), which enables full circulatory and respiratory support, have increased with the aim to achieve haemodynamic stabilization in patients with severe or rapidly deteriorating infarct-related cardiogenic shock. 

Sign Up or Log In as a healthcare professional to read the full article.

Share via

Also worth reading

People also read:

covid-19 Self-Test Kits
COVID-19 Self-Test Kits

The Singapore government has recently announced that COVID-19 self-test kits are now available to the general public for purchase at retail pharmacies. This mode of

Read More »